Product Information
PAROXETINE ER 25 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4048 per EA under NDC 42858070503. Its NADAC has been published 398 times since Nov 14, 2018.
Strength
25 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858070503
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209293On Market Since
9/14/2018
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 25 MG TABLET has been published 398 times since Nov 14, 2018, and over the history we have for it it has declined 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4048 per EA |
|---|---|
| All-time high | $2.2144 (Dec 12, 2018) |
| All-time low | $0.3584 (Nov 20, 2024) |
| 52-week high | $0.5084 |
| 52-week low | $0.3809 |
| Median price | $0.9051 |
| Average price | $0.9701 |
| Largest weekly change | +53.5% (Jul 19, 2023) |
| Weeks tracked | 398 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PAROXETINE HYDROCHLORIDE HEMIHYDRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 25 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.4048 per EA (NDC 42858070503), effective Jun 24, 2026.
How has the price of PAROXETINE ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 25 MG TABLET has declined 81.1%. It has been tracked across 398 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 25 MG TABLET?
Since Nov 14, 2018, the NADAC for PAROXETINE ER 25 MG TABLET has ranged from a low of $0.3584 (Nov 20, 2024) to a high of $2.2144 (Dec 12, 2018), with a median of $0.9051 per EA.
Are there cheaper alternatives to PAROXETINE ER 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE ER 25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 25 MG TABLET?
PAROXETINE ER 25 MG TABLET (NDC 42858070503) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification